Rasat Tablet 0.5 mg (Rasagiline Mesylate)

Adult dose

This drug is administered orally to adults once daily as monotherapy or adjunctive therapy. 1) Monotherapy or adjunctive therapy to a dopamine agonist: Administer 1 mg orally once daily. 2) Adjunctive therapy to levodopa: The recommended initial dose for patients taking levodopa is 0.5 mg once daily. If well tolerated and the clinical response is insufficient, the dose may be increased to 1 mg once daily. This drug may be taken with or without food.

This medication should not be used by patients who are allergic to the active ingredient or other components. Additionally, it should not be administered to patients who are taking other MAO inhibitors, certain analgesics, cough medications, or those who have stopped such medication within the last 2 weeks. It is also not safe to use this medication in patients with moderate to severe liver function impairment. During treatment, various side effects such as flu-like symptoms, skin cancer, leukopenia, allergies, appetite reduction, depression, hallucinations, headaches, conjunctivitis, dizziness, angina, rhinitis, dermatitis, musculoskeletal pain, urinary urgency, fever, and fatigue may occur; hence, caution is advised. In particular, when taken with levodopa, movement disorders or low blood pressure may occur, and consultation with a healthcare provider is necessary. This medication can cause drowsiness or sudden sleep, so caution must be exercised when driving or operating machinery, and it can be dangerous when taken with sedatives or alcohol. Additionally, symptoms of impulse control disorders, such as compulsive behavior or pathological gambling, may appear during treatment, so both patients and caregivers should closely monitor for changes. If pregnant or breastfeeding, it is crucial to consult with a healthcare provider regarding the use of this medication, and careful consideration should be given to dosing or use in children and the elderly. In cases of overdose, severe symptoms may occur, and immediate medical attention should be sought. This medication has many interactions with other medications; thus, inform healthcare professionals about any other medications being taken. Finally, keep this medication out of the reach of children, and store it in a suitable environment to maintain its quality.

• influenza
• skin cancer
• leukopenia
• allergy
• loss of appetite
• depression
• hallucinations
• headache
• cerebrovascular accident
• conjunctivitis

This medication should be stored in a sealed container to protect it from air or moisture. It is crucial to keep it in a cool place, between 1 to 25 degrees Celsius, to maintain its effectiveness.

Appearance

White round tablet

Package unit

30 tablets/box [(10 tablets/PTP X 3)]